Pharmacy Update

Disclaimer: We are getting frequent COVID-related questions about drug concerns and potential interactions. This information is as of July 9, 2020. We will do our best to keep you up to date with this ever evolving situation. This is the most update information at the time of publication.

Note: There are no Food and Drug Administration (FDA) approved therapies for treatment or prevention of COVID-19. If at all possible, it is best to have patients enrolled in a clinical trial.

In this issue:

PRESS RELEASE: COMPARATIVE ANALYSIS SHOWS REMDESIVIR MORTALITY REDUCTION IN SEVERE COVID-19 

UPDATE: HYDROXYCHLOROQUINE WITH OR WITHOUT AZITHROMYCIN IN COVID-19 

DOSE DEPENDENT INCREASES ODDS OF COVID-19 INFECTION WITH PROTON PUMP INHIBITOR (PPI) USE 

UPDATE: MEDFORMIN ER RECALL 

EXPANDED FDA/CDC WARNING ON METHANOL CONTAMINATED HAND SANITIZER

Read more